Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Onivyde (irinotecan liposome injection) for the Treatment of Metastatic Pancreatic Cancer

Drug Name (Brand / Generic)

Onivyde / MM-398 / irinotecan liposome injection

Company / Licensee

Merrimack Pharmaceuticals / Baxalta

Therapy Class

Topoisomerase inhibitor

Current Indication

Metastatic pancreatic cancer

Market Sector

Oncology

Development Status

Approved in the US and Taiwan
Expand

Go Top